Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1184233422
总结
TPMT *1/*2 + *1/*3A + *1/*3C is associated with increased likelihood of hematological toxicity when treated with mercaptopurine or purine analogues in people with Leukemia as compared to TPMT *1/*1.